Last reviewed · How we verify

NCT04065763

Correlation of the Dural Sac Dimension With the Spread of Spinal Anesthesia

Completed Last updated 11 March 2020
What this trial tests

trial testing Ultrasound assessment of dural sac dimension in Elderly Patients in 41 participants. Completed in 14 February 2020.

Timeline
10 October 2019
Primary endpoint
14 February 2020
14 February 2020

Quick facts

Lead sponsorSMG-SNU Boramae Medical Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment41
Start date10 October 2019
Primary completion14 February 2020
Estimated completion14 February 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

SMG-SNU Boramae Medical Center

Who can join

65 and older, female only, with Elderly Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cerebrospinal fluid volume is an important factor that influences peak block height and regression of sensory and motor blockade. The aim of this study is to evaluate the effect of dural sac dimension on the spread of spinal anesthesia in elderly patient using ultrasound.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Elderly Patients

Currently open trials in the same condition.

Other SMG-SNU Boramae Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04065763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing